Abstract
Glyconanoparticles are very useful tools for proteomic and glycomics research. They mainly contain glycosylated gold nanoparticles, glycosylated quantum dots, and magnetic glyconanoparticles. This review summarized the glyconanoparticle progress on biolabeling, in vitro or in vivo imaging, biosensing, targeted drug delivery, and other biomedical applications in recent years. The core of glyconanoparticle applications is to study the carbohydrate-mediated interactions, which opens the new field in glycobiology.
Keywords: Gold glyconanoparticles, glycosylated quantum dots, magnetic glyconanoparticles, applications, proteomic, glycomics research, targeted drug delivery, biosensing, carbohydrate-mediated interactions, glycobiology
Current Pharmaceutical Design
Title:Recent Progress on the Applications of Multifunctional Glyconanoparticles
Volume: 19 Issue: 13
Author(s): Gangliang Huang, Fei Cheng, Xin Chen, Daquan Peng, Xiancheng Hu and Guoming Liang
Affiliation:
Keywords: Gold glyconanoparticles, glycosylated quantum dots, magnetic glyconanoparticles, applications, proteomic, glycomics research, targeted drug delivery, biosensing, carbohydrate-mediated interactions, glycobiology
Abstract: Glyconanoparticles are very useful tools for proteomic and glycomics research. They mainly contain glycosylated gold nanoparticles, glycosylated quantum dots, and magnetic glyconanoparticles. This review summarized the glyconanoparticle progress on biolabeling, in vitro or in vivo imaging, biosensing, targeted drug delivery, and other biomedical applications in recent years. The core of glyconanoparticle applications is to study the carbohydrate-mediated interactions, which opens the new field in glycobiology.
Export Options
About this article
Cite this article as:
Huang Gangliang, Cheng Fei, Chen Xin, Peng Daquan, Hu Xiancheng and Liang Guoming, Recent Progress on the Applications of Multifunctional Glyconanoparticles, Current Pharmaceutical Design 2013; 19 (13) . https://dx.doi.org/10.2174/1381612811319130014
DOI https://dx.doi.org/10.2174/1381612811319130014 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Diffuse Large B Cell Lymphoma
Current Stem Cell Research & Therapy Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Anti-Cancer Agents in Medicinal Chemistry Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Hemangiomas, Angiosarcomas, and Vascular Malformations Represent the Signaling Abnormalities of Pathogenic Angiogenesis
Current Molecular Medicine Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
Current Cancer Drug Targets MicroRNA Expression in Coronary Artery Disease
MicroRNA The Use of Statins in Hematopoietic Stem Cell Transplantation
Current Stem Cell Research & Therapy B-lymphocytes as Targets for Therapy in Chronic Cold Agglutinin Disease
Cardiovascular & Hematological Disorders-Drug Targets Preclinical Overview of WHI-07, A Novel Nucleoside Analog-based Dual- Function Microbicide
Current Medicinal Chemistry - Anti-Infective Agents Helicobacter pylori Biofilm and New Strategies to Combat it
Current Molecular Medicine Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
Current Cancer Drug Targets Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Current Pharmaceutical Design Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Current Pharmaceutical Design The Expanding Role of APRIL in Cancer and Immunity
Current Molecular Medicine Regulation of Autophagy by Sphingolipids
Anti-Cancer Agents in Medicinal Chemistry Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Current Pharmaceutical Design Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets